Marked increase in anticonvulsant activity but decrease in wet-dog shake behaviour during short-term treatment of...

Area of Science:

• Neuroscience
• Pharmacology
• Epilepsy Research

Background:

• Valproic acid (VPA) is a widely used anticonvulsant.
• The mechanisms underlying VPA's efficacy, particularly with repeated dosing, require further elucidation.
• Amygdala-kindled rat models are crucial for studying seizure activity and anticonvulsant drug effects.

Purpose of the Study:

• To investigate the impact of single versus repeated valproic acid (VPA) administration on anticonvulsant activity in amygdala-kindled rats.
• To explore the relationship between VPA pharmacokinetics and its enhanced anticonvulsant efficacy with repeated dosing.
• To differentiate the mechanisms responsible for VPA's anticonvulsant effects and its associated side effects like wet-dog shakes.

Main Methods:

• Amygdala-kindled rats were administered valproic acid (VPA) at 200 mg/kg i.p. either as a single dose or repeatedly (7 doses over a short period).
• Seizure severity, duration, and after-discharge duration were measured.
• Plasma concentrations of VPA and its metabolites, as well as drug levels in the substantia nigra, were determined.
• Wet-dog shake behavior was monitored as an indicator of a specific VPA-induced side effect.

Main Results:

• Single VPA administration reduced seizure severity and duration but offered limited complete protection (12%).
• Repeated VPA dosing significantly increased complete seizure protection to 88%.
• This enhanced anticonvulsant activity did not correlate with increased VPA plasma concentrations or accumulation in the substantia nigra.
• Wet-dog shake behavior was attenuated with repeated dosing, suggesting different mechanisms for anticonvulsant effects and side effects.

Conclusions:

• Short-term, repeated administration of valproic acid (VPA) markedly enhances its anticonvulsant efficacy in amygdala-kindled rats.
• The increased efficacy is not mediated by drug accumulation or altered pharmacokinetic profiles.
• VPA's anticonvulsant effects and wet-dog shake behavior appear to be mediated by distinct neurobiological mechanisms, as evidenced by the differential effects of repeated dosing and a VPA metabolite (trans-2-en-VPA).